Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Amado Rafael Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2023 4 Amado Rafael (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 39,300 shares @ $0
Granted 55,200 options to buy @ $2.76, valued at $152.4k
04/14/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/05/2023 4 Amado Rafael (See Remarks) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 113,217 options to buy @ $33.95, valued at $3.8M
Granted 21,564 options to buy @ $0
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/11/2022 4 Amado Rafael (EVP of R&D) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 19,120 shares @ $0
Paid exercise price by delivering 8,464 shares @ $11.8265, valued at $100.1k
10/05/2022 4 Amado Rafael (EVP of R&D) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Paid exercise price by delivering 8,968 shares @ $11.0617, valued at $99.2k
08/02/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 2,000 shares @ $11.97, valued at $23.9k
07/06/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 2,000 shares @ $11.44, valued at $22.9k
06/22/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 2,000 shares @ $11.18, valued at $22.4k
05/19/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 11,500 shares @ $7.3993, valued at $85.1k
03/25/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 237,358 shares @ $0
Granted 368,589 options to buy @ $9.69, valued at $3.6M
03/17/2022 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 5,169 shares @ $7.709, valued at $39.8k
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 24,866 shares @ $0
Granted 92,365 options to buy @ $33.78, valued at $3.1M
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2020 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 30,800 shares @ $0
Granted 109,600 options to buy @ $18.22, valued at $2M
09/05/2019 4 Amado Rafael (EVP of R&D and CMO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 105,162 shares @ $0
Granted 160,630 options to buy @ $26.15, valued at $4.2M
09/05/2019 3 Amado Rafael (EVP of R&D and CMO) has filed a Form 3 on Allogene Therapeutics, Inc.
08/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/16/2019 4 Amado Rafael (President, R & D) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 3,028 shares @ $5.3694, valued at $16.3k
01/08/2019 4 Amado Rafael (President, R & D) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 1,006,224 options to buy @ $0
Granted 224,724 options to buy @ $0
08/07/2018 4 Amado Rafael (President, R & D) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 678,720 options to buy @ $0
01/17/2018 4 Amado Rafael (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 859,968 options to buy @ $0
Granted 192,060 options to buy @ $0
01/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy